rich 1.0 The U.S. Food and Drug Administration (FDA) gave a green light Monday to the first human trial of a potential Zika vaccine. Inovio Pharmaceuticals and GeneOne Life Science are at the helm of the study and have already conducted promising animal trials. They say that they will begin phase one with 40 healthy adults in the next coming weeks. Dubbed GLS-5700, the vaccine is based on synthetic fragments of virus DNA that stimulate antibodies, according to the Guardian. TIME's Top Stories https://audioboom.com/channels/3380207-time-s-top-stories Audioboom https://audioboom.com 480 95 https://audioboom.com/i/22662896/600x600/c 600 600 <iframe width="100%" height="95" src="https://embeds.audioboom.com/posts/4727959/embed?v=202301" style="background-color: transparent; display: block; padding: 0; width: 100%" frameborder="0" allowtransparency="allowtransparency" scrolling="no" title="Audioboom player" allow="autoplay" sandbox="allow-downloads allow-forms allow-popups allow-same-origin allow-scripts allow-storage-access-by-user-activation allow-top-navigation-by-user-activation"></iframe>